Clinical trial
CTS2190 Phase I /II Clinical Study in Patients
NCT06224387
Study timeline
Study start (actual)2023-06-26Date precision: day
Registry last updated2024-08-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Solid Tumorsunresolved
Pancreatic Cancerunresolved
Non-small Cell Lung Cancerunresolved
Triple-negative Breast Cancerunresolved
Interventions
CTS2190 capsulesDRUG
Sponsors & collaborators
CytosinLab Therapeutics Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06224387 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.